RBM8A and breast carcinoma: Furthermore, Kaplan–Meier survival analysis showed that breast cancer patients with high HSPD1, RBM8A, or G3BP1 expression respectively had significantly worse distant metastasis-free survival (DMFS) in the TCGA Cohort (Fig. S7B).